Atlas Trials

A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Clinical trial NCT04272775 · TERMINATED

Trial details

NCT number
NCT04272775
Sponsor
Takeda
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed and/or Refractory Multiple Myeloma
Start date
2012-06-05
Primary completion
2019-02-15
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.